medigraphic.com
SPANISH

NCT Neumología y Cirugía de Tórax

ISSN 2594-1526 (Electronic)
Antes Revista del Instituto Nacional de Enfermedades Respiratorias

Ver anteriores al 2010

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • Policies
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 2

<< Back Next >>

Neumol Cir Torax 2013; 72 (2)

Epidemiology of pleural effusion in the INER, 2011-2012

Sosa-Juárez A, García-Sancho C, Sánchez-Hernández JD, Jaime-Capetillo ME, Fernández-Plata R, Martínez-Briseño D, Torre-Bouscoulet L, Pérez-Padilla R
Full text How to cite this article

Language: Spanish
References: 9
Page: 136-141
PDF size: 199.57 Kb.


Key words:

Pleural effusion, epidemiology, mortality.

ABSTRACT

Objective: To determine the causes of pleural effusion, biochemical characteristics, hospital stay, mortality and associated factors in patients hospitalized at the National Institute of Respiratory Diseases Ismael Cosío Villegas (2011-2012). Patients and methods: Were recruited patients had results that include: a) biochemical study of pleural effusion, b) patients in whom the etiology was documented malignant or benign tumor and c) that could be classified as exudate or transudate. The analysis was carried out using STATA 9.0. Results and conclusions: We included 364 patients who had complete information (80.4%). The main results were: a) proportion of infectious effusions: 52% (TB, 16.2%; pneumonia and parapneumonic, 24.7%; empyema, 11.1%), followed by thoracic cancer (33.5%); b) there was no differences in the proportion of patients with pleural exudates from malignant or benign; c) benign effusions showed an increase in pleural DHL, and pleural fluid cholesterol (LP), in contrast, malignant effusions showed higher proportion polymorphonuclear cells and lymphocytes in LP; d) there was no difference in days of hospitalization and mortality among patients with benign or malignant effusion.


REFERENCES

  1. Light RW. Pleural effusions. Med Clin North Am 2011;95:1055-1070.

  2. Sahn SA. Getting the most from pleural fluid analysis. Respirology 2012;17:270-277.

  3. García LP, Salazar-Lezama, MA. Etiología del derrame pleural en el Instituto Nacional de Enfermedades Respiratorias. Rev Inst Nal Enf Resp Mex 1999;12:97-100.

  4. Marel M, Zrustová M, Stasný B, et al. The incidence of pleural effusion in a well-defined region. Epidemiologic study in Central Bohemia. Chest 1993;104:1486-1489.

  5. Franco-Marina F, Villalba-Caloca J. La epidemia de cáncer pulmonar en México. Rev Inst Nal Enf Resp Mex 2001;14:207-214.

  6. Salazar MA, Cuadra CJ, Quiroz RH, et al. Correlación adenosindesaminasa/ linfocitos en el líquido pleural de origen tuberculoso. Rev Inst Nal Enf Respir 1997;10:160-163.

  7. Lubart E, Lidgi M, Leibovitz A, Rabinovitz C, Segal R. Mortality of patients hospitalized for active tuberculosis in Israel. Isr Med Assoc J 2007;9:870-873.

  8. Aliberti S, Amir A, Peyrani P, et al. Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia. Chest 2008;134:955-962.

  9. Szklo M, Nieto FJ. Epidemiology: beyond the basics. Basic Study Designs in Analytical Epidemiology. Gaithersburg, Maryland: Aspen Publishers; 2000.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Neumol Cir Torax. 2013;72